Description: Matricelf Ltd, a biotechnology company, develops a platform for autologous matrix and cells implants for a range of medical conditions. Its regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction et al. The company was founded in 2019 and is based in Ness Ziona, Israel.
Home Page: www.matricelf.com
Golda Meir 3
Ness Ziona,
Israel
Phone:
972 5 04057353
Officers
| Name | Title |
|---|---|
| Dr. Asaf Toker M.D. | Chief Exec. Officer |
| Ms. Sigal Russo-Gueta | Chief Financial Officer |
| Mr. Alon Sinai | COO & Director |
| Prof. Tal Dvir Ph.D. | CSO & Director |
Exchange: TA
Country: IL
Currency: Israeli Agora (ILA)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | |
| Full Time Employees: | 0 |